The US AI Drug Discovery Market is poised for unprecedented expansion, projected to reach a staggering USD 2,494.89 million by 2035, up from USD 211.57 million in 2024. This remarkable increase represents a compound annual growth rate (CAGR) of 25.15%, highlighting the sector's transformative potential. Factors driving this growth include the integration of artificial intelligence into drug...